Risk factors
Adial Pharmaceuticals (ADIL) risk factors
Item 1A of every Adial Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
63 risks, 4 new, 5 dropped, 8 reworded since the prior year. Adial Pharmaceuticals highlights new collaboration risks with Molteni for AD04, healthcare price-control regulations, and federal shutdown impacts.
Filed Mar 05, 2026 - FY2024 10-K risk factors
64 risks. Clinical stage biotechnology company dependent on lead product candidate AD04 for treating alcohol use disorder.
Filed Mar 04, 2025